Piribo: The Latest Option and Evaluation Agreements in the Pharmaceutical and Biotechnology Sectors Examined in New Report

LONDON--(Business Wire)--
Piribo, the online destination for business intelligence for the biotech and
pharmaceutical industry, has added a new report which provides details of the
latest option and evaluation agreements announced in the pharmaceutical and
biotechnology sectors.

The report Option & Evaluation Agreements in Pharma and Biotech offers a
comprehensive understanding and unprecedented access to the option and
evaluation partnering agreements entered into by the worlds leading biopharma
companies. It explains how and why companies enter option and evaluation deals.

Understanding the flexibility of a prospective partner's negotiated deals terms
provides critical insight into the negotiation process in terms of what you can
expect to achieve during the negotiation of terms. Whilst many smaller companies
will be seeking details of the payments clauses, the primary concern is how
payments are triggered.

This report contains over 400 links to online copies of actual option and
evaluation contract documents as submitted to the Securities Exchange Commission
by pharma/biotech companies and their partners. Contract documents provide the
answers to questions about a prospective partner's flexibility on a wide range
of important issues, many of which will have a significant impact on each
party's ability to derive value from the deal.

The 399-page report covers the following areas:

* Trends in option and evaluation deal-making in the biopharma industry since
2000
* Analysis of option and evaluation deal structure
* Case studies of real-life option and evaluation deals
* Access to over 400 option and evaluation contract documents
* The leading option and evaluation deals by value since 2000
* Most active option and evaluation dealmakers since 2000
* The leading option and evaluation partnering resources

The report "Option & Evaluation Agreements in Pharma and Biotech" is available
from Piribo. For further information, please visit:

http://www.piribo.com/publications/deals_alliances/licensing/option_evaluation_agreements_pharma_biotech.html

About Piribo.

Piribo (http:www.piribo.com) is a UK-based independent online store supplying
business information on the pharmaceutical and biotechnology industries. The
website now carries over 10,000 English language titles including, market
reports, studies and books and is the UK`s largest online biopharma information
store. Subscribers receive a free monthly newsletter and email alerts on new
titles in their areas of interest. The company was established in 2004.

Piribo
Edwin Bailey, +44 (0)207 060 1099

Copyright Business Wire 2009